Overview

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis

Status:
Recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
The aim of this clinical trial is to assess the safety of: - single doses of the study drug CHF6333 in Healthy Volunteers (HVs) and in subjects with Bronchiectasis (BE) - Part I - repeated doses of the study drug CHF6333 in subjects with BE - Part II
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Chiesi Farmaceutici S.p.A.